Cargando…
Seroprevalence of severe acute respiratory coronavirus virus 2 (SARS-CoV-2) antibodies among healthcare personnel in the Midwestern United States, September 2020–April 2021
OBJECTIVE: To determine the prevalence of severe acute respiratory coronavirus virus 2 (SARS-CoV-2) IgG nucleocapsid (N) antibodies among healthcare personnel (HCP) with no prior history of COVID-19 and to identify factors associated with seropositivity. DESIGN: Prospective cohort study. SETTING: An...
Autores principales: | Bosserman, Rachel E., Farnsworth, Christopher W., O’Neil, Caroline A., Cass, Candice, Park, Daniel, Ballman, Claire, Wallace, Meghan A., Struttmann, Emily, Stewart, Henry, Arter, Olivia, Peacock, Kate, Fraser, Victoria J., Budge, Philip J., Olsen, Margaret A., Burnham, Carey-Ann D., Babcock, Hilary M., Kwon, Jennie H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cambridge University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428156/ https://www.ncbi.nlm.nih.gov/pubmed/37592963 http://dx.doi.org/10.1017/ash.2022.375 |
Ejemplares similares
-
Antibodies in healthcare personnel following severe acute respiratory syndrome coronavirus virus 2 (SARS-CoV-2) infection
por: Bosserman, Rachel E., et al.
Publicado: (2022) -
2316. SARS-CoV-2 N-antibody Seropositivity in Healthcare Personnel without a Known History of COVID-19
por: Tiwary, Sajal K, et al.
Publicado: (2023) -
Clinical and occupational risk factors for coronavirus disease 2019 (COVID-19) in healthcare personnel
por: Kwon, Jennie H., et al.
Publicado: (2022) -
Coronavirus disease 2019 (COVID-19) vaccine breakthrough infections among healthcare personnel, December 2020–April 2021
por: Nickel, Katelin B., et al.
Publicado: (2022) -
Randomized Controlled Trial of Oral Vancomycin Treatment in Clostridioides difficile-Colonized Patients
por: Fishbein, Skye R. S., et al.
Publicado: (2021)